Alberto L’Abbate

Dr. Alberto L’Abbate

Institute of Biomembranes, Bioenergetics, and Molecular Biotechnologies—National Research Council (IBIOM-CNR), Bari, Italy
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2010 in Genome Research
Verified
Journal Article
Open access
PDF file
CSClelia Tiziana Storlazzi
Clelia Tiziana Storlazzi
ALAngelo Lonoce
Angelo Lonoce
MGMaria C. Guastadisegni
Maria C. Guastadisegni
DTDomenico Trombetta
Domenico Trombetta
Pietro D'AddabboPietro D'Addabbo
Pietro D'Addabbo
MRMariano Rocchi
Mariano Rocchi
Double minutes (dmin) and homogeneously staining regions (hsr) are the cytogenetic hallmarks of genomic amplification in cancer. Different mechanisms have been proposed to explain their genesis. Recently, our group showed that the MYC-containing dmin in leukemia cases arise by excision and amplification (episome model). In the present paper we investigated 10 cell lines from solid tumors showing MYCN amplification as dmin or hsr. Particularly revealing results were provided by the two subclones of the neuroblastoma cell line STA-NB-10, one showing dmin-only and the second hsr-only amplification. Both subclones showed a deletion, at 2p24.3, whose extension matched the amplicon extension. Additionally, the amplicon structure of the dmin and hsr forms was identical. This strongly argues that the episome model, already demonstrated in leukemias, applies to solid tumors as well, and that dmin and hsr are two faces of the same coin. The organization of the duplicated segments varied from very simple (no apparent changes from the normal sequence) to very complex. MYCN was always overexpressed (significantly overexpressed in three cases). The fusion junctions, always mediated by nonhomologous end joining, occasionally juxtaposed truncated genes in the same transcriptional orientation. Fusion transcripts involving NBAS (also known as NAG), FAM49A, BC035112 (also known as NCRNA00276), and SMC6 genes were indeed detected, although their role in the context of the tumor is not clear.

17 July 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ALAlberto L’Abbate
Alberto L’Abbate
GMGemma Macchia
Gemma Macchia
Pietro D'AddabboPietro D'Addabbo
Pietro D'Addabbo
ALAngelo Lonoce
Angelo Lonoce
DTDoron Tolomeo
Doron Tolomeo
CSClelia Tiziana Storlazzi
Clelia Tiziana Storlazzi
The mechanism for generating double minutes chromosomes (dmin) and homogeneously staining regions (hsr) in cancer is still poorly understood. Through an integrated approach combining next-generation sequencing, single nucleotide polymorphism array, fluorescent in situ hybridization and polymerase chain reaction-based techniques, we inferred the fine structure of MYC-containing dmin/hsr amplicons harboring sequences from several different chromosomes in seven tumor cell lines, and characterized an unprecedented number of hsr insertion sites. Local chromosome shattering involving a single-step catastrophic event (chromothripsis) was recently proposed to explain clustered chromosomal rearrangements and genomic amplifications in cancer. Our bioinformatics analyses based on the listed criteria to define chromothripsis led us to exclude it as the driving force underlying amplicon genesis in our samples. Instead, the finding of coexisting heterogeneous amplicons, differing in their complexity and chromosome content, in cell lines derived from the same tumor indicated the occurrence of a multi-step evolutionary process in the genesis of dmin/hsr. Our integrated approach allowed us to gather a complete view of the complex chromosome rearrangements occurring within MYC amplicons, suggesting that more than one model may be invoked to explain the origin of dmin/hsr in cancer. Finally, we identified PVT1 as a target of fusion events, confirming its role as breakpoint hotspot in MYC amplification.

7 May 2013 in Nature Communications
Verified
Journal Article
Open access
PDF file
LLLuca Lignitto
Luca Lignitto
AAAntonella Arcella
Antonella Arcella
MSMaria Sepe
Maria Sepe
LRLaura Rinaldi
Laura Rinaldi
RDRossella Delle Donne
Rossella Delle Donne
AFAntonio Feliciello
Antonio Feliciello
Human glioblastoma is the most frequent and aggressive form of brain tumour in the adult population. Proteolytic turnover of tumour suppressors by the ubiquitin-proteasome system is a mechanism that tumour cells can adopt to sustain their growth and invasiveness. However, the identity of ubiquitin-proteasome targets and regulators in glioblastoma are still unknown. Here we report that the RING ligase praja2 ubiquitylates and degrades Mob, a core component of NDR/LATS kinase and a positive regulator of the tumour-suppressor Hippo cascade. Degradation of Mob through the ubiquitin-proteasome system attenuates the Hippo cascade and sustains glioblastoma growth in vivo. Accordingly, accumulation of praja2 during the transition from low- to high-grade glioma is associated with significant downregulation of the Hippo pathway. These findings identify praja2 as a novel upstream regulator of the Hippo cascade, linking the ubiquitin proteasome system to deregulated glioblastoma growth.


3 January 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
DTDomenico Trombetta
Domenico Trombetta
PGPaolo Graziano
Paolo Graziano
ASAldo Scarpa
Aldo Scarpa
ASAngelo Sparaneo
Angelo Sparaneo
GRGiulio Rossi
Giulio Rossi
LMLucia Anna Muscarella
Lucia Anna Muscarella
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression

3 June 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ALAlberto L’Abbate
Alberto L’Abbate
CCCrocifissa Lo Cunsolo
Crocifissa Lo Cunsolo
EMEttore Macrì
Ettore Macrì
PIPaolo Iuzzolino
Paolo Iuzzolino
CMCristina Mecucci
Cristina Mecucci
CSClelia Tiziana Storlazzi
Clelia Tiziana Storlazzi
The progression of low-risk del(5q) myelodysplastic syndrome to acute myeloid leukemia is increased when associated with mutations of TP53, or with additional chromosomal abnormalities. However, to date the prognostic impact and molecular consequences of these rearrangements were poorly investigated. Single additional alterations to del(5q) by balanced chromosome rearrangements were rarely found in myelodysplasia. In particular, balanced alterations involving TP63 and FOXP1 genes were never reported in the literature.